In The Netherlands, Bakhuizen et al. [33] revealed in 370 women diagnosed with BC < 30 years of age not carrying any deleterious variants in BRCA1/2 eight (2.2%) TP53 germline pathogenic variants. This evidence concerns the gene BRCA1 and breast cancer.